2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
11
Osteoporosis
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Colonic Neoplasms
5
Neoplasms
4
Obesity
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Inflammation
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bone Diseases, Metabolic
3
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Leukemia
2
Leiomyoma
2
Giant Cell Tumor of Bone
2
Gastrointestinal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Bone Diseases
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Surveys and Questionnaires
6
Cisplatin
6
Brachytherapy
5
Doxorubicin
4
Docetaxel
4
Pemetrexed
3
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
FANG vaccine
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Vitamin D
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled